share_log

68% Of This Incyte Insider's Holdings Were Sold

68% Of This Incyte Insider's Holdings Were Sold

這位 Incyte Insider 持有的股份有 68% 被出售
Simply Wall St ·  2023/11/06 08:53

Insiders were net sellers of Incyte Corporation's (NASDAQ:INCY ) stock during the past year. That is, insiders sold more stock than they bought.

在過去的一年中,業內人士是Incyte公司(納斯達克股票代碼:INCY)股票的淨賣家。也就是說,內部人士賣出的股票多於他們買入的股票。

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

儘管我們認爲股東不應簡單地關注內幕交易,但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。

View our latest analysis for Incyte

查看我們對Incyte的最新分析

The Last 12 Months Of Insider Transactions At Incyte

Incyte 最近 12 個月的內幕交易

Over the last year, we can see that the biggest insider sale was by the Executive VP & Chief Medical Officer, Steven Stein, for US$1.4m worth of shares, at about US$63.28 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The good news is that this large sale was at well above current price of US$54.85. So it may not shed much light on insider confidence at current levels. Steven Stein was the only individual insider to sell shares in the last twelve months.

去年,我們可以看到,執行副總裁兼首席醫療官史蒂芬·斯坦以每股約63.28美元的價格出售了價值140萬美元的股票,股價約爲63.28美元。雖然我們通常不喜歡看到內幕拋售,但更令人擔憂的是銷售是否以較低的價格進行。好消息是,這次大甩賣的價格遠高於目前的54.85美元。因此,在目前的水平上,它可能無法爲內部人士的信心提供太多啓示。史蒂芬·斯坦是過去十二個月中唯一一位出售股票的個人內部人士。

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

您可以看到下圖所示的去年的內幕交易(公司和個人)。如果你想確切地知道誰賣了,賣了多少錢,什麼時候賣了,只需點擊下面的圖表即可!

insider-trading-volume
NasdaqGS:INCY Insider Trading Volume November 6th 2023
納斯達克證券交易所:2023年11月6日incy內幕交易量

I will like Incyte better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些大筆的內幕買入,我會更喜歡Incyte。在我們等待的同時,請查看這份免費名單,列出了最近有大量內幕買入的成長型公司。

Insider Ownership

內部所有權

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Incyte insiders own 0.5% of the company, worth about US$64m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

我喜歡看看內部人士在一家公司擁有多少股份,以幫助我了解他們與內部人士的一致性。較高的內部人所有權通常會使公司領導層更加關注股東的利益。看來Incyte內部人士擁有該公司0.5%的股份,價值約6400萬美元。當然,我們在其他地方看到了更高的內幕所有權水平,但這些持股足以表明內部人士與其他股東保持一致。

What Might The Insider Transactions At Incyte Tell Us?

Incyte的內幕交易可能會告訴我們什麼?

There haven't been any insider transactions in the last three months -- that doesn't mean much. We don't take much encouragement from the transactions by Incyte insiders. But we do like the fact that insiders own a fair chunk of the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 1 warning sign for Incyte you should know about.

在過去的三個月中,沒有任何內幕交易——這並不意味着什麼。Incyte內部人士的交易並沒有給我們帶來太大的鼓舞。但是我們確實喜歡內部人士擁有公司很大一部分股份這一事實。雖然我們喜歡了解內部人士的所有權和交易情況,但在做出任何投資決定之前,我們也一定要考慮股票面臨的風險。每家公司都有風險,我們發現了Incyte的1個警告信號,你應該知道。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想看看另一家公司——一家財務狀況可能優越的公司——那麼千萬不要錯過這份免費的股本回報率高、債務低的有趣公司的名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論